Science & Technology
SBIR Phase I: Determination of the Mechanisms Driving Diseases at the Molecular Network Level to Develop Disruptive Drug Candidates
National Science Foundation
Opportunity #: 2451628
Award Ceiling
$304K
Award Floor
$304K
Close Date
Mar 31, 2026
16 days leftTotal Funding
$304K
Expected Awards
1
Posted Date
Mar 21, 2025
Cost Sharing Required
No
Grants.gov ID
sbir-2451628
Description
SBIR Phase Phase I award: "SBIR Phase I: Determination of the Mechanisms Driving Diseases at the Molecular Network Level to Develop Disruptive Drug Candidates" awarded to Core Biotherapeutics, Inc in Ladera Ranch, California. Funded by National Science Foundation. Award amount: $303,864. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.